Skip to content
Business

BASF Raises Its Evonik Bid to €24 a Share, but Evonik Still Refuses Talks

Evonik's board has turned down BASF's improved €24-a-share approach, worth about €11.2bn and a 39% premium, saying it will stay independent. BASF called the refusal to negotiate incomprehensible.

The Evonik Industries headquarters tower in Essen, Germany, with the Evonik name on its roof, seen from beneath a road bridge.
Photo: Ostrovsky Alexander (Островский Александр) / Wikimedia Commons, CC BY-SA 3.0

Evonik has rejected a second takeover approach from BASF. Its board said it would not open negotiations even after the bid was raised to €24 a share, which values the Essen-based speciality chemicals group at about €11.2bn and, by BASF's count, is a premium of about 39% to Evonik's undisturbed share price. BASF called the decision incomprehensible.

The rebuff, reported on Friday morning, leaves Germany's largest chemicals company without a negotiating partner a little over a month after it first approached its smaller rival. Evonik's executive board said it would keep working on its own plans and develop the group as an independent company. It left the door open only to purely informative and confidential contacts, so that BASF can set out why it wants the deal.

The improved approach

  • €24 per Evonik share
  • €11.2bn implied value of Evonik
  • 39% premium to the undisturbed price, says BASF

From €22.15 to €24 in Four Weeks

The approach became public on 25 September, when Evonik said it had received a non-binding approach from BASF about a voluntary public takeover offer for all its shares. The RAG-Stiftung, which holds 43% of Evonik and is its largest shareholder, said BASF had also contacted it. Evonik shares closed 7.2% higher that day and BASF fell 3.6%. At the time BASF was worth about €45.8bn on the stock market and Evonik about €9.2bn.

Evonik turned down that first proposal, worth about €22.15 a share or roughly €10.3bn, as too low. On 23 October people close to the deal said BASF had raised the price to €24 a share, about €11.18bn in total. Evonik shares closed 2.7% higher at €21.26 that day, leaving the reported offer about 13% above the market price. BASF shares were 0.15% higher. Over the week to 23 October BASF lost 1.47%, to €52.45.

Aerial view of Steamcracker II and surrounding plants at the BASF site in Ludwigshafen beside the Rhine, with a flare burning.
Aerial view of Steamcracker II and surrounding plants at the BASF site in Ludwigshafen beside the Rhine, with a flare burning. Photo: Rolf Kickuth / Wikimedia Commons, CC BY-SA 4.0

BASF Puts Jobs and Sites on the Table

BASF has tried to win over the people with the most say in Evonik's future. It said it would honour existing agreements that protect Evonik jobs if a takeover went ahead. That matters in North Rhine-Westphalia, Evonik's home state, whose government said earlier this month that a deal must not put Evonik jobs or the company's independent development at risk. The chairman of BASF's own works council, Sinischa Horvat, has said its existing site agreement remains in force.

In its reply to Friday's rejection BASF called its offer attractive and pointed again to its commitments to employees and sites. It said it could not understand why Evonik's board would not even negotiate, calling that stance "incomprehensible".

Why BASF Wants a Bigger Chemicals Group

The case for a deal rests on scale in a weak European market. The region's chemicals makers have been hurt by high energy costs and soft demand, and BASF chief executive Markus Kamieth said in June that conditions were the most difficult in at least 25 years as industrial power shifts to Asia. BASF also risks losing its long-held place as the world's largest chemicals company by revenue to China's Sinopec. Its 2025 group revenue of €59.7bn was roughly level with Sinopec's chemicals business.

The two companies overlap only in part. Evonik makes high-performance plastics, animal feed additives and ingredients for coatings and household products. BASF covers engineering plastics, super-absorbent polymers, vitamins and a long list of industrial chemicals. Europe is the biggest market for both.

BASF reported its own third-quarter figures on 28 October. Sales rose to €16.4bn from €14.3bn and EBITDA before special items climbed to €1.6bn from €1.4bn, and the company raised its full-year forecast for that profit measure to €7.4bn to €7.8bn, from €6.9bn to €7.7bn. Net income slipped to €155m from €172m.

Evonik has its own plans. People familiar with the matter told Reuters this month that it has been looking at a purchase of the US speciality chemicals company Ashland, valued at about $3.3bn. A source said BASF sees an Evonik-Ashland combination as too risky.

What Investors Watch Next

Points to watch

  • Whether BASF takes its case directly to shareholders through a formal public offer, where the RAG-Stiftung's 43% stake would weigh heavily.
  • How the RAG-Stiftung responds to the higher price. It declined to comment after the raised bid was first reported.
  • The gap between Evonik's share price and the €24 BASF has put forward, as a gauge of how likely investors think a deal is.
  • Any move by Evonik on Ashland, which would change the shape of any combination.

A takeover is far from certain. Evonik's board has now said no twice, and the RAG-Stiftung's 43% stake makes it the single most important voice on any bid.

Sources

Related stories

Markets

BASF Raises Its 2026 Profit Forecast as Higher Prices Lift Third-Quarter Sales 14%

BASF lifted its 2026 EBITDA forecast to €7.4bn to €7.8bn as higher prices pushed third-quarter sales up 14% to €16.4bn, though restructuring and a €318m writedown left an operating…

Business

Volkswagen Sinks to a €5.8bn Quarterly Operating Loss on Porsche Writedown

Volkswagen swung to a third-quarter operating loss of €5.8 billion after €7.8 billion of special items, led by a €6.4 billion impairment on Porsche goodwill and about €1 billion in…

Business

Alstom Shares Crash 26% After a Second Profit Warning Over Delayed German Trains

Alstom shares closed 26% lower at €11.685 after the train maker cut its margin target from 6.5% to about 1% and warned of about €1.5bn of cash burn, blaming delays on regional…

Business

Schaeffler to Cut 3,460 Jobs and Close Five European Sites as Combustion Demand Fades

Schaeffler will cut a net 3,460 jobs across 16 European sites, about 2,660 of them in Germany, and close five, including Dortmund and Morbach, as demand for combustion-engine cars…

Business

Québecor Makes a C$31bn Cash-and-Share Bid for Telus, Which Warns of Regulatory Risk

Québecor has offered C$6.35 in cash plus 0.17 of its own shares for each Telus share, a bid worth about C$31bn. The Telus board says the price falls short and the regulatory risk…

Business

Tyson Foods Shares Jump 8.7% as Beef Outlook Outweighs a $74m Quarterly Loss

Tyson Foods posted a $74m fourth-quarter net loss and adjusted EPS of $0.61, down 47%, yet its shares closed 8.7% higher on Monday as its 2027 beef outlook pointed to far smaller…

Business

Roche Wins FDA Approval for Breast Cancer Pill Wilserdly After 62% Cut in Progression Risk

The FDA approved Roche's all-pill Wilserdly combination for ESR1-mutated advanced breast cancer after it cut the risk of progression or death by 62%. A ruling on early-stage use is…

Business

ULA Loses Its First Mission as Vulcan Rocket Fails With 40 Amazon Leo Satellites on Board

United Launch Alliance's Vulcan rocket failed about 10 minutes after lift-off on Sunday, and all 40 Amazon Leo satellites were lost. Amazon fell 3.3% on Monday as space stocks…